Cargando…
The Case against Antibiotics and for Anti-Virulence Therapeutics
Although antibiotics have been indispensable in the advancement of modern medicine, there are downsides to their use. Growing resistance to broad-spectrum antibiotics is leading to an epidemic of infections untreatable by first-line therapies. Resistance is exacerbated by antibiotics used as growth...
Autores principales: | Hotinger, Julia A., Morris, Seth T., May, Aaron E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537500/ https://www.ncbi.nlm.nih.gov/pubmed/34683370 http://dx.doi.org/10.3390/microorganisms9102049 |
Ejemplares similares
-
Antibodies Inhibiting the Type III Secretion System of Gram-Negative Pathogenic Bacteria
por: Hotinger, Julia A., et al.
Publicado: (2020) -
Animal Models of Type III Secretion System-Mediated Pathogenesis
por: Hotinger, Julia A., et al.
Publicado: (2019) -
Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components
por: Hotinger, Julia A., et al.
Publicado: (2021) -
Phage-Related Ribosomal Proteases (Prps): Discovery, Bioinformatics, and Structural Analysis
por: Hotinger, Julia A., et al.
Publicado: (2022) -
Development of Anti-Virulence Therapeutics against Mono-ADP-Ribosyltransferase Toxins
por: Lugo, Miguel R., et al.
Publicado: (2020)